You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (1) |
Back to Search
Pharmacokinetics and pharmacodynamics of new purine-2,6-dione–based pde4/7 inhibitors in rats
- At: Glasgow (Scotland) (2018)
- Type: Poster
- Poster code: POS-PAA-015
- By: WYSKA, Elzbieta (Jagiellonian University Medical College, Department of Pharmacokinetics and Physical Pharmacy)
- Co-author(s): Elżbieta Wyska
Artur Świerczek: Department of Pharmacokinetics and Physical Pharmacy, Jagiellonian University Medical College, Kraków, Poland
Krzysztof Pociecha: Department of Pharmacokinetics and Physical Pharmacy, Jagiellonian University Medical College, Kraków, Poland
Marietta Ślusarczyk: Department of Medicinal Chemistry, Jagiellonian University Medical College, Kraków, Poland
Agnieszka Jankowska: Department of Medicinal Chemistry, Jagiellonian University Medical College, Kraków, Poland
Grażyna Chłoń-Rzepa: Department of Medicinal Chemistry, Jagiellonian University Medical College, Kraków, Poland
Maciej Pawłowski: Department of Medicinal Chemistry, Jagiellonian University Medical College, Kraków, Poland - Abstract:
Background
Rheumatoid arthritis (RA) is a debilitating autoimmune disorder for which no fully effective treatment exists. The encouraging results of preclinical studies on selective phosphodiesterase (PDE) 4 inhibitors using animal models of this disease has prompted us to search for new antirheumatic compounds acting as dual PDE inhibitors that
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026